Foghorn Therapeutics
FHTX
#9648
Rank
HK$0.80 B
Marketcap
HK$13.48
Share price
-3.37%
Change (1 day)
-62.50%
Change (1 year)

EPS for Foghorn Therapeutics (FHTX)

EPS in 2026 (TTM): -HK$7.20

According to Foghorn Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$7.21. In 2025 the company made an earnings per share (EPS) of -HK$9.25 an increase over its 2024 EPS that were of -HK$12.38.

EPS history for Foghorn Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$7.20-22.15%
2025-HK$9.25-25.32%
2024-HK$12.38-32.48%
2023-HK$18.34-10.69%
2022-HK$20.54-4.03%
2021-HK$21.40-56.18%
2020-HK$48.83169.62%
2019-HK$18.1172.21%
2018-HK$10.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$10.58 46.74%๐Ÿ‡บ๐Ÿ‡ธ USA